Navigation path

Pharmaceuticals - Union Register


Register of not active orphan medicinal products


Product information

Alpha-1 proteinase inhibitor

EU orphan designation number: EU/3/06/350
Active ingredient: Alpha-1 proteinase inhibitor
Indication: Treatment of emphysema secondary to congenital alpha-1 antitrypsin deficiency
Sponsor: Octapharma (IP) Limited
The Zenith Building, 26 Spring Gardens, Manchester M2 1AB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/02/2006 Orphan designation EMEA/OD/092/05 (2006)551 of 16/02/2006
26/03/2009 Change of name and/or address of sponsor
17/01/2019 Removal of orphan designation from Community Register